Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Figueroa, C. Velasco Suarez (Buenos Aires, Argentina). Effect of combined therapy with oral azythromicin and betametasone, and nasal budesonide in children with sleep disordered breathing associated with adenotonsillar hypertrophy and rhinosinusitis. Eur Respir J 2013; 42: Suppl. 57, 2594

Member's Comments

No comment yet.

Related content which might interest you: Long-term effects of nasal budesonide administered to children with mild obstructive sleep-disordered breathing Source: Eur Respir J 2004; 24: Suppl. 48, 477s Year: 2004 Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Comparison between adenotonsillectomy and adenoidectomy in the treatment of obstructive sleep apnea in children Source: International Congress 2015 – New findings in sleep-disordered breathing in children Year: 2015 Myofunctional treatment of sleep disordered breathing in children Source: Annual Congress 2013 –Lung function and sleep studies in children: technical aspects and clinical applications Year: 2013 Nasal budesonide ameliorates symptoms and polysomnography findings in children with chronic nasal obstruction and mild sleep-disordered breathing Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003 Efficacy of intranasal corticosteroid therapy on lower respiratory tract responsiveness in children with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006 Effect of nasal CPAP on nasal symptoms in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013 The effect of nasal tramazoline with dexamethazone in obstructive sleep apnoea patients Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly Year: 2014 Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006 The efficacy of CPAP and oral appliances in moderate obstructive sleep apnoea, used as CBO guideline states Source: International Congress 2014 – Sleep disordered breathing 1 Year: 2014 Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Drug-induced sleep endoscopy predictors for oral appliance treatment outcome Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing Year: 2013 Adenotonsillectomy revisited: Outcomes in 54 children with sleep disordered breathing after adenotonsillectomy Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome Year: 2016 The efficacy of oral appliance in patients with severe obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014 Efficacy testing for oral appliance therapy in obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea Source: Eur Respir J 2005; 25: 521-527 Year: 2005 Low-dose inhaled and nasal corticosteroid use and the risk of cataracts Source: Eur Respir J 2006; 27: 1168-1174 Year: 2006 Nasal inflammation and sleep quality with continuous positive airway pressure (CPAP) therapy in obstructive sleep apnoea Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013